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A common feature of the mammalian septin gene family is complex genomic architecture with multiple
alternate splice variants. Septin 9 has 18 distinct transcripts encoding 15 polypeptides, with two transcripts
(SEPT9_v4 and v4*) encoding the same polypeptide. We have previously reported that the ratio of these
distinct transcripts is altered in neoplasia, with the v4 transcript being the usual form in normal cells but
v4* becoming predominant in tumours. This led us to ask what the functional differences between these
two transcripts might be. The 50-UTRs of v4 and v4* have distinct 50 ends encoded by exons 1b (v4) and
1z and 2 (v4*) and a common 30 region and initiating ATG encoded within exon 3. Here we show that the
two mRNAs are translated with different efficiencies and that cellular stress can alter this. A putative internal
ribosome entry site can be identified in the common region of the v4 and v4* 50-UTRs and translation is
modulated by an upstream open-reading frame in the unique region of the v4 50-UTR. Germline mutations
in hereditary neuralgic amyotrophy (HNA) map to the region which is common to the two UTRs. These
mutations dramatically enhance the translational efficiency of the v4 50-UTR, leading to elevated SEPT9_v4
protein under hypoxic conditions. Our data provide a mechanistic insight into how the HNA mutations can
alter the fine control of SEPT9_v4 protein and its regulation under physiologically relevant conditions and
are consistent with the episodic and stress-induced nature of the clinical features of HNA.
INTRODUCTION
The genetic screens of Hartwell for cell division cycle mutants
led to the discovery of a series of genes with functions in cyto-
kinesis (1). Among these were a series of genes that were shown
to encode P loop GTP-binding regions whose products were
localized to the bud neck during cytokinesis in Saccharomyces
cerevisiae. Such genes have been called septins and are now
known to be evolutionarily conserved with multiple members
in species in all kingdoms except plants (2,3). In yeast, septin
proteins can form filaments and localize to the cytokinetic
ring during cytokinesis, acting as membrane diffusion barriers.
In animals cells, the range of septin functions appears to
be much greater, and they have roles in cytokinesis, vesicle
trafficking, cell polarity, cytoskeletal dynamics, apoptosis,
neurodegeneration and neoplasia (2–4). At least 13 septin
genes are known in mammals such as man and extensive alter-
nate splicing is a common feature. The subcellular localization
of human septin proteins is diverse (5), and a wide range of
hetero-oligomeric septin complexes are believed to participate
in cellular processes (6). The properties and functions of these
septin-containing complexes remain poorly understood but
interactions with cytoskeletal elements including actin and
tubulin as well as interactions with a range of other cellular pro-
teins such as MAP4, HIF1a and signalling molecules such as
rhotekin have recently been described (7–10).
Some clues to septin functions have come from the study of
human disease, and there is compelling evidence for septins
having a role in neoplasia (11). For example, several septins
have been identified as in-frame fusions with MLL in leukae-
mia (12), and SEPT9 was originally identified at a region of
allelic imbalance in ovarian and breast cancer (13,14). More-
over, the murine SEPT9 locus is a common site for integration
by lymphomagenic retroviruses (15). Altered expression of
several septins has been observed in diverse malignancies
(2,16,17). Our own laboratory has focussed on SEPT9, and
we have shown this to have 18 distinct transcripts (based on
multiple transcription start sites) that encode 15 polypeptides
(18). A range of studies have shown that in neoplasia there
are altered patterns of SEPT9 transcripts expressed with over-
# The Author 2007. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org
*To whom correspondence should be addressed. Tel: +44 2890329241 ext. 2221; Fax: +44 2890263744; Email: seh.russell@qub.ac.uk
Human Molecular Genetics, 2007, Vol. 16, No. 7 742–752
doi:10.1093/hmg/ddm003
 at Queens University of Belfast on November 19, 2012
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
expression of SEPT9_v1 and v4 (17,19). Of note is that there
are two distinct transcripts, SEPT9_v4 and v4, both with very
long 50-UTRs that encode the same polypeptide and that in
neoplasia we see a dramatic alteration of the normal ratio of
these species (17,19,20). The SEPT9_v4 protein has a
number of properties that suggest a role in neoplasia. For
example, over-expression of this protein induces altered cell
polarity and increased motility (21). We have also observed
that expression of this isoform can alter microtubule dynamics
(our unpublished results) and displace high molecular SEPT9
isoforms from filamentous structures (21).
Septins have also been implicated in other diseases and, in par-
ticular, in neurological conditions (2). Recently, Kuhlenbaumer
et al. (22) reported that germline mutations could be found in
SEPT9 in six of nine kindreds with the autosomal dominant con-
dition hereditary neuralgic amyotrophy (HNA). Haplotype
analysis excluded a founder effect in these kindreds (22). In
this condition, patients experience episodic pain and wasting of
muscles in the limbs and especially the arms, often triggered by
inter-current infection, prolonged exercise and other stress
(23,24). Five of themutations map to exon 3 of SEPT9. Although
these mutations contribute to the open-reading frame of the long
SEPT9 isoforms (v1, v2 and v3), we have not found that these
missense mutations have a discernible phenotype when engin-
eered in expression constructs (unpublished data). Since exon 3
is a common element of the 50-UTRs of both SEPT9_v4 and
v4, we speculated that the mutations might alter the function
of these long untranslated regions. A clue to the role of transla-
tional control being important in the production of the
SEPT9_v4 protein isoform came from its expression from two
distinct SEPT9 transcripts that both have long .700 bp
50-UTRs. The majority of mRNAs has short 50-UTRs ,200 bp;
however, in the subsetwith long 50-UTRs, themajority represents
genes involved in growth control or other regulatorymechanisms
(25,26). We therefore investigated the properties of 50-UTRs in
SEPT9_v4 and v4 and discovered that they are translated with
different efficiencies and respond differently to cellular stresses.
Furthermore, we found that the disease-associated HNA
mutations alter these responses. The data presented here
provide new insight into septin gene regulation and the pertur-
bations that occur in both neoplasia and HNA.
RESULTS
The SEPT9_v4 and SEPT9_v4 50-UTRs have potential
for differential translational control
The 50-UTRs of SEPT9_v4 and _v4 transcripts differ only in
their extreme 50ends, i.e. exon 1b and exons 1z and 2, respect-
ively (Fig. 1A). Both then splice into the same acceptor site of
exon 3 (18), with coding beginning with the AUG at position
400 in this exon. Examination of the sequences indicates that
both UTRs are G/C-rich (.60%). Modelling using mFold
suggests both have the potential for extensive secondary struc-
ture (data not shown) with high predicted free energy
dG ,2 300 Kcal/mol. Both UTRs contain a number of
uAUGs within their unique regions (v4 has five uAUGs and
v4 has two uAUGs) and one in their common region of
exon 3 (Fig. 1B). Closer examination of the context of the
sequence surrounding these uAUGs (Fig. 1B) indicates that
only two uAUGs at positions 7 and 240 of exon 1b are in
strong context relative to the Kozak consensus sequence
(A/G)CC(A/G)CCAUGG (27) Crucially, these contain a G
at position þ4 and a purine at position 23. These therefore
represent potential upstream open-reading frames (uORFs)
of eight (uORF 1) and 31 amino acids (uORF 2), respectively
(Fig. 1B). It is noteworthy that these are in frame with exon 3
AUG from which translation of the SEPT9_v4 protein begins.
The SEPT9_v4 and SEPT9_v4 transcripts
are translated with different efficiencies
To investigate potential translational control, both 50-UTRs
were cloned upstream of the SEPT9_v4 ORF in
pcDNA3.1MycHis(þ)B and used to transfect HeLa cells.
Translation from the SEPT9_v4 construct was consistently
higher than that observed with the SEPT9_v4 construct
when controlled for transfection efficiency (v5-tagged
protein in Fig. 2A) and loading (tubulin in Fig. 2A). This
difference is not due to transcriptional effects, since relative
mRNA copy numbers are not significantly different when
compared with real-time RT–PCR (Fig. 2B).
Figure 1. Comparison of SEPT9_v4 and SEPT9_v4 50-UTRs. (A) Represen-
tation of known SEPT9 transcripts including alternative splicing of exons 1b,
1z and 2 into a common splice site in exon 3, which generates two transcripts
(SEPT9_v4 and _v4) differing in the extreme 50 end of their 50-UTRs.
Only one of the three possible 30 splice variants (a) is represented (18). The
asterisk represents the stop codon. Non-coding regions are indicated by
open boxes and common coding ORF by filled boxes. (B) The location of
upstream start codons (uAUGs) and two uORFs with uAUGs in strong
context relative to Kozak consensus sequence is demonstrated. The location
of point mutations identified in patients with HNA is also indicated (C262T
and C278T, respectively).
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A further comparison of the two full-length mRNAs was
carried out by investigating their response to etoposide-
induced stress. Etoposide inhibits DNA topoisomerase II,
thereby inhibiting DNA synthesis. Cells transfected with full-
length transcripts in pcDNA3.1MycHis(þ)B were treated with
increasing concentrations of etoposide. To determine copy
number, real-time RT–PCR shows that both constructs
exhibit a comparable reduction in transcription when etopo-
side is added to the medium (Fig. 2D), but thereafter there
is no significant difference in transcript levels. Translation
from the SEPT9_v4 construct decreases with increasing con-
centration of etoposide. This is particularly evident in longer
exposures of western blots of the SEPT9_v4-derived Myc-
tagged protein (as in Fig. 2C). This was confirmed by densito-
metry (Supplementary Material, Fig. S1).
For the SEPT9_v4 construct, there was an initial decrease
in translation at the lowest drug concentration (presumably as
a result of reduced global cellular transcription), but thereafter
translation was refractory to increasing concentration of drug
(Fig. 2C). These observations are again consistent with differ-
ent translatability of the two SEPT9_v4 splice variants. Com-
parable observations were made with other stresses such as
hydrogen peroxide (data not shown).
We next used a luciferase reporter construct to compare the
two 50-UTR sequences. Both full-length 50-UTRs and the
common and the unique regions were inserted upstream of
the firefly luciferase reporter gene in the PGL-2 promoter
vector (Fig. 3A) in both orientations. These constructs were
co-transfected into Cos-7 cells along with a Renilla luciferase
plasmid (phRL-TK) for 24 h. Firefly luciferase activity was
measured and normalized to Renilla luciferase activity as
transfection efficiency control and expressed relative to the
activity of parental PGL-2 vector (Fig. 3B). The results indi-
cate that the SEPT9_v4, SEPT9_v4 full-length 50-UTRs and
the common region of the two transcripts all enhance reporter
gene activity significantly (P , 0.05) when compared with
parental vector. Constructs containing the regions of 50-UTR
in reverse orientation had a minor inhibitory effect due to
the insertion of ~700 bp upstream of a reporter (data not
shown). Greatest reporter activity was observed with the
common region. This was followed by the SEPT9_v4
50-UTR construct, which showed significantly more activity
than the SEPT9_v4 50-UTR (P , 0.001). Northern blot-
ting for firefly luciferase (Fig. 3C) shows that this is not due
to a transcriptional effect nor is it due to altered transfection
efficiencies (Renilla blot in Fig. 3C).
To investigate potential promoter activity in any of these
regions, we cloned the same 50-UTR fragments into the promo-
terless PGL-2 Basic vector (PGL-2B). These were co-transfected
into Cos-7 cells and normalized and expressed relative to the
Figure 2. Effect of 50-UTR on translational control of SEPT9_v4/SEPT9_v4 expression. (A) Full-length SEPT9_v4 and SEPT9_v4 (coding sequence plus 50-UTR)
were cloned into pCDNA3.1 Myc-tagged vector, transfected into the HeLa cell line and probed for Myc-tagged protein, re-probed for V5-tagged MEKK as transfec-
tion control and b-tubulin loading control. (B) Results of real-time RT–PCR control for Myc-tagged constructs normalized to b-actin levels and expressed relative
to SEPT9_v4 levels. Data represent the results of at least three independent experiments carried out in triplicate. (C) Western blot of HeLa cells transfected with
full-length SEPT9_v4 and SEPT9_v4 and treated with varying concentrations of etoposide. Note that the SEPT9_v4-derived Myc-tagged panel represents a
longer exposure to demonstrate the gradual decrease in protein level with increasing drug concentration. (D) Results of real-time PCR control for transgene expression
following etoposide treatment. The data represent the results of at least three independent experiments carried out in triplicate. ns ¼ not significant.
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PGL-2P promoter (þve control containing SV40 promoter). No
promoter activitywas observedwhen comparedwith the parental
PGL-2B (Fig. 3D), which suggests that the unique regions of
SEPT9_v4 and SEPT9_v4 may modulate activity of a positive
translational effect mediated by the common region.
Translation of SEPT9_v4 splice variants is
regulated by an IRES
The data presented thus far are consistent with a role for
sequence(s) in the common region exerting an effect on trans-
lation of the SEPT9_v4 ORF. To determine whether a discrete
part of the common region was responsible, fragments of the
common region were amplified, cloned into PGL2-P and
transfected into Cos-7 cells (Fig. 4A). All fragments in the
reverse orientation reduced translation to a level below that
of vector (data not shown). Fragments 123–174, 123–278
and 243–278 generated a comparable reduction in translation
even in the forward orientation. In contrast, fragments 0–174,
0–278, 123–416 and 243–416 caused no such inhibition of
translation and indeed may have had a minor positive effect.
However, none of these reached statistical significance. The
fact that the effect is only seen with the full-length fragment
suggests that the translational effect may be multi-partite
and probably structural or conformational in nature.
We therefore speculated that such a structure which could
influence translation might be an internal ribosome entry site
(IRES) which should also facilitate cap-independent trans-
lation. To test this, the SEPT9_v4, v4 50-UTRs and also the
common region were inserted into the intercistronic region
of the PRF bicistronic vector (28) (Fig. 5A). Bicistronic
vectors are considered the ‘gold standard’ when defining
IRES activity, and this vector encodes Renilla luciferase as
the first cistron and firefly luciferase as the second cistron.
The ratio of second/first cistron (firefly/Renilla luciferase)
expression can be used as a measure of cap-independent trans-
lation and IRES activity; with the important caveats that
alternative splicing, promoter activity and ribosome shunting
can generate second cistron activity independently of internal
ribosome entry and bias the assay. The data generated when
Figure 3. Analysis of effects of SEPT9_v4/SEPT9_v4 50-UTRs on translation of monocistronic luciferase reporter. (A) Various 50-UTR sequences were cloned
into the HindIII site upstream of the firefly luciferase reporter in PGL-2 promoter vector (PGL-2P). (B) The effect of SEPT9_v4, v4, common and unique region
of 50-UTR (forward orientation) on translation of luciferase reporter relative to parental PGL-2 promoter vector in Cos-7 cells are shown. Results were normal-
ized to Renilla luciferase transfection control and expressed relative to parental PGL-2 promoter vector. (C) Northern blot analysis of RNA from luciferase
reporter construct transfection in Cos-7 cell line, probed for firefly luciferase open-reading frame stripped and re-probed for Renilla luciferase. (D) Effect of
SEPT9_v4, v4, common and unique region of 50-UTRs when cloned upstream of the luciferase reporter in the promoterless PGL2-Basic luciferase construct
(PGL-2B). These were co-transfected into Cos-7 cells, normalized to Renilla luciferase transfection control and expressed relative to the SV40 promoter contain-
ing PGL-2 promoter vector. There were no significant differences. v4 or v4F ¼ SEPT9_v4/ v4 in forward orientation; v4Un or v4UnF ¼ SEPT9_v4/ v4
unique region in forward orientation; ComF ¼ SEPT9_v4/ v4 common region in forward orientation; v4 or v4R ¼ SEPT9_v4/ v4 in reverse orientation;
v4Un or v4UnR ¼ SEPT9_v4/ v4 unique region in reverse orientation; ComR ¼ SEPT9_v4/ v4 common region in reverse orientation.
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Cos-7 cells were transfected with these constructs indicate that
all three constructs facilitate the second cistron expression
1.5–2.5-fold the c-Myc IRES activity (Fig. 5B). Interestingly,
in contrast to monocistronic constructs (Fig. 3B), the
SEPT9_v4 50-UTR in this model exhibits greater activity
than the SEPT9_v4 and common region (Fig. 5B), possibly
indicating that a cap-dependent control mechanism is
negated in the context of the bicistronic vector. Northern
blot analysis of RNA from Cos-7 transfections proved diffi-
cult; however, bands of the appropriate size, up-shifted
when compared with parental PRF vector were observed
(Fig. 5C, upper panel). Furthermore, no lower monocistronic
or alternatively spliced products were visualized when
probed for firefly luciferase, indicating that transcripts are
full length. The differences in transcript levels appear to be
a result of transfection efficiency, as when the blot was
re-probed for Renilla luciferase (Fig. 5C, lower panel),
similar intensity of bands was observed. In addition, we
demonstrate that neither the SEPT9_v4 or _v4 sequences
contain a cryptic promoter, since deletion of the SV40 promo-
ter leads to a dramatic reduction in activity (Fig. 4D).
We also demonstrated that these observations cannot be
accounted for by ribosome shunting from the first to second
cistron. We cloned the 50-UTRs and the common region into
the PhpRF vector which contains a stable hairpin upstream of
cistron one and which dramatically inhibits translation and
therefore prevents shunting. Transfection of these constructs
into the Cos-7 cell line showed that the presence of a hairpin
had no effect on the second cistron expression in PhpRMF,
PhpRv4F and PhpRv4F (Fig. 5F), whereas the first cistron
activity is dramatically decreased in all four vectors (Fig. 5E).
Taken together, these observations are consistent with the pre-
sence of an IRES in the common region of the 50-UTRs of the
SEPT9_v4 and v4 transcripts. However, our initial data had
shown different translational efficiencies of the two full-length
transcripts, and we therefore speculated that this might be due
to sequence(s) in their respective unique regions which regulate
the IRES. We have previously noted two in-frame uAUGs
(A7T and A240T) in a strong context in the SEPT9_v4 unique
region. We used site-directed mutagenesis to mutate these
AUGs (Fig. 6A) and observed that mutation of A7T caused a
dramatic reduction in protein expression. Mutation of A240T
had no effect on translation (Fig. 6B). These observations
cannot be explained by variable transfection efficiencies or
loading effects (V5-tagged control and tubulin blots, respect-
ively, in Fig. 6B). Real-time RT–PCR also indicates that these
differences are not due to transcriptional effects (Fig. 6C). We
therefore provide compelling evidence for translational control
of the SEPT9_v4 protein by two distinct mRNAs.
HNA-associated mutations alter translational
control of SEPT9_v4
The translational control of the SEPT9_v4 protein by two dis-
tinct mRNAs casts new light on the functional significance of
recently described germline mutations in HNA. Although
these mutations are described as mapping to coding sequence
in SEPT9 isoforms v1–v3 (22), we noted that they are also
within the region of exon 3, which we now define as important
for regulation of translation of SEPT9_v4 (i.e. the common
region). We therefore engineered into full-length SEPT9_v4
and v4 constructs a disease-associated mutation (C262T)
reported in several distinct kindreds affected by HNA
(Fig. 7A). Although these mutations may cause amino acid
substitutions in SEPT9_v1, v2 and v3 protein, it is notable
that they lie in predicted stem-loop structures of the
Figure 4. Deletion mapping of the region common to SEPT9_v4 and _v4 50-UTRs. (A) A series of fragments from the common region (exon 3) of both 50-UTRs
were cloned upstream of luciferase reporter in PGL-2 promoter vector. (B) Luciferase assay in Cos-7 cells of deletion constructs, normalized to Renilla luciferase
transfection control and expressed relative to parental PGL-2 promoter vector. All luciferase figures represent the results of at least three independent exper-
iments carried out in triplicate. ComF ¼ SEPT9_v4/ v4 common region in forward orientation.
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SEPT9_v4 50-UTR common region. The v4 wild-type and
C262T mutant function similarly under normoxic as well as
hypoxic conditions (Supplementary Material, Fig. S2) or
other stresses (data not shown). In stark contrast, although
under normoxic conditions the wild-type and C262T
SEPT9_v4 constructs behave similarly, the C262T is much
more efficiently translated under hypoxic conditions
(Fig. 7B). The real-time RT–PCR analysis of RNA indicates
that the relative transgene transcript levels show a comparable
increase in the hypoxic cells (Fig. 7C) and that under nor-
moxia and hypoxia, the transcript levels are not significantly
different.
Figure 5. The effect on translation of SEPT9_v4 and SEPT9_v4 50-UTRs in a bicistronic luciferase reporter gene analysis. (A) Representation of a series of
bicistronic constructs which were generated to include an intercistronic insertion of 50-UTRs, location of hairpin upstream of Renilla luciferase and excision of
SV40 promoter. (B) Bicistronic luciferase assay in Cos-7 cell line, expressed as ratio of second cistron activity (firefly luciferase) over first cistron activity
(Renilla luciferase) expressed relative to the activity of c-myc IRES. (C) Northern blot analysis of RNA from bicistronic luciferase reporter construct transfection
in Cos-7 cell line, probed for firefly luciferase open-reading frame stripped and re-probed for Renilla luciferase. (D) Effect of promoter excision on luciferase
activity from transfection of bicistronic construct in Cos-7 cell line. Data represent luciferase activity of promoterless construct expressed relative to that of
parental construct containing an SV40 promoter. (E and F) Luciferase activity following insertion of hairpin upstream of first cistron (Renilla luciferase)
and transfection into Cos-7 cell line. Figures represent raw Renilla (E) and firefly (F) luciferase activity with/without hairpin. All luciferase figures represent
the results of at least three independent experiments carried out in triplicate.
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DISCUSSION
A wide range of mechanisms exist to ensure that cells have the
correct levels of particular polypeptides for normal cellular
function. Although many genes are regulated by mechanisms
that control the production of mRNA species, post-
transcriptional mechanisms are also of crucial importance,
and considerable evidence now points to the importance of
control of translation. The translation of mRNAs in eukaryotic
cells is principally controlled by 5-methyl-guanine cap depen-
dent mechanisms, but there is increasing evidence for the role
of internal ribosome entry as a second physiologically relevant
mechanism (29). Although originally described in picorna-
viruses, a range of cellular circumstances have been discov-
ered, in which cap-dependent translation is perturbed and
where IRES can allow effective translation (30). For
example, this phenomenon is well described in development,
differentiation (31,32) and also during apoptosis and the cell
cycle (29,33). It also occurs when cells are stressed by geno-
toxins, hypoxia, nutrient restriction and physical insults such
as heat and cold shock (30). Many of these processes are
characterized by partial or global shutdown of normal tran-
scriptional and other biosynthetic processes (including cap-
dependent translation) or where there is a need for highly
regulated (spatially and/or temporally) production of specific
polypeptides.
Cellular IRESs have recently been uncovered in transcripts
that encode various growth-related proteins. It is proposed that
translation occurs utilizing the IRES in situations where cap-
dependent translation is inhibited (30,34,35). However,
unlike viral IRES, which can usually be mapped to discrete
sequences, cellular IRESs frequently comprise multiple non-
overlapping sequences and their major determinant may be
their three-dimensional structure (36). The presence of
upstream start codons (uAUGs) and uORFs also influence
translational efficiency from IRES or canonical AUG by pro-
cesses such as stalling, re-initiation and shunting. uORFs can
also encode polypeptides that can act on the translational
machinery itself (37). For example, genes as diverse as
CD36, MDM2, ERBB2, SOC1 and RARB have experimen-
tally characterized uORFs that regulate translation (37).
The range of genes whose transcripts are regulated by
IRES-based mechanisms is rapidly growing (30; and see
IRES data base at http://www.iresite.org/) and includes tran-
scription factors (c-myc, N-myc, c-jun, RUNX1 and so
on), stress response factors (Apaf-1, Bag-1, APC and so on),
growth factors and their receptors (ERa, VEGF, PDGF,
FGF-2, IGF-1 receptor and so on), cytoskeletal and cell–cell
contact proteins (ARC, MAP2, connexins), signalling mol-
ecules and kinases, components of the translational machinery
itself (eIF4G1, NAT1) as well as an array of channel proteins,
transporters and other proteins (betaF1-ATPase, neurogranin,
Figure 6. Effect of uORF mutation on expression of SEPT9_v4. (A) Site-directed mutagenesis was used to generate point mutations (AUG! AUU) which
abolished uORF 1 (A7T) and uORF 2 (A240T) in full-length expression constructs of SEPT9_v4 in pCDNA3.1 Myc-tagged vector. (B) Western blot analysis
of transfection of mutant constructs (Myc-tagged protein) in HeLa cell line, re-probed for V5-tagged MEKK as transfection control and b-tubulin loading
control. (C) Results of real-time PCR control for Myc-tagged wild-type and mutant constructs normalized to b-actin levels and expressed relative to
SEPT9_v4 wild-type levels. The figure represents the results of at least three independent experiments carried out in triplicate. The differences were not stat-
istically significant.
748 Human Molecular Genetics, 2007, Vol. 16, No. 7
 at Queens University of Belfast on November 19, 2012
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
FMR1). Moreover, it is increasingly recognized that disease
states can be associated with mutations leading to alterations
in the translational control of particular mRNA species. For
example, considerable data now exist, which suggests that
neoplasia can be associated with perturbed translational
control of key cellular regulators including FGF-2, c-myc,
p53, HIF1a and VEGF (38–40). Neurological diseases are
also associated with alterations in translational control
(41–43). For example, IRES activity has been shown to be
disrupted in the 50-UTR of connexin-32 mRNA, leading to
perturbed connexin levels and a subtype of Marie–Charcot–
Tooth disease (44), and the gene encoding fragile X syndrome
protein has an IRES (45). A characteristic of these physiologi-
cal and pathological situations is the need for careful regu-
lation (spatial and temporal) of particular protein isoforms.
A feature of the septins is the formation of hetero-
oligomeric protein complexes (2,3,6) involving multiple
septin species. Evidence also exists for homotypic association
of septin proteins and the potential formation of complexes
made up of different isoforms of a particular septin (46; Pent-
land, Russell and Hall, unpublished data). In this regard,
SEPT9 is of note, since 15 polypeptides are produced from
18 transcripts generated by alternate splicing (18). Alterations
in SEPT9 expression have been described in neoplasia and, in
particular, alterations in the ratio of SEPT9_v4 and v4 tran-
scripts (19,20). Furthermore, germline mutations have been
found in exon 3 of SEPT9 in HNA (22). We can find no
evidence of these mutations altering any so far detectable
property of those isoforms (SEPT9_v1, v2 and v3) that
utilize exon 3 as part of an open-reading frame (unpublished
data). In contrast, we do see a clear effect of mutations in
exon 3 used as part of the 50-UTR of the SEPT9_v4 and v4
transcripts. These results indicate that the germline mutation
in patients with HNA may have a significant effect on
SEPT9_v4 translation during stress such as hypoxia and
therefore is physiologically relevant to the episodic nature of
induction of HNA.
The data presented here provide new insights into these
phenomena by demonstrating the potential for translational
control of the SEPT9_v4 transcripts with the existence of a
regulatable (v4) and a non-regulatable (v4) transcript. Thus,
we have discovered that the SEPT9_v4 protein is regulated
by translational control. We demonstrate the presence of an
IRES in the common region of the 50-UTR of these two tran-
scripts and show that the unique regions confer on this differ-
ential translational efficiencies. We show that an in-frame
upstream AUG in a strong context facilitates translation
from the IRES and that stress responses modulate the transla-
tional efficiency of the IRES. Finally, we demonstrate that the
disease-associated HNA mutations alter these responses. It is
of note that other septin genes produce multiple transcripts
by alternate splicing and SEPT8 (for example) also produces
two distinct transcripts that encode the same polypeptide
(47). It may therefore be that translational control is a
general mechanism for the regulation of septin polypeptide
expression, and we would posit that the proteins made by
this mechanism have crucial regulatory roles in septin
biology. An important future step will be to determine the
physiological circumstances under which the SEPT9 tran-
scripts are regulated by IRES mechanisms. For example, do
these mechanisms have a role during the cell cycle? This is
an attractive model since septins were first identified as
alleles of genes with cytokinesis phenotypes. In addition,
there is abundant evidence for spatially regulated translational
control of genes in neuronal physiology and this may be rel-
evant to SEPT9 and possibly to other septins.
On the basis of the data presented here and our previous
data (21), a model might then be proposed where
SEPT9_v4 is a non-regulated transcript and where the v4
transcript is highly regulatable. Introduction of the
disease-associated C262T mutation leads to deregulation of
SEPT9_v4 translation and, under hypoxic stress, enhanced
SEPT9_v4 protein production. Given that the SEPT9_v4 poly-
peptide can have dramatic effects of cellular behaviour and
that SEPT9 is known to influence microtubule behaviour, per-
turbed SEPT9_v4 protein expression could alter microtubule
function in critical cells such as long axons. HNA is associated
with episodic bouts of axonal dysfunction that can be precipi-
tated by inter-current illness, infection and extreme exercise.
Such stresses may then normally regulate SEPT9 isoform
expression. Loss of this crucial isoform regulation in the pre-
sence of C262T HNA-associated mutations may lead to
altered stoichiometry of SEPT9 isoforms and hence altered
function. Similarly, in neoplasia, the ratio of these transcripts
changes (17,19,20) by altered methylation and perhaps by
other mechanisms, resulting in a predominance of the non-
regulatable SEPT9_v4 transcript and leading to increased
levels of SEPT9_v4 protein again with altered stoichiometry
Figure 7. Effect of HNA mutation on expression of SEPT9_v4 in response to
hypoxia. (A) Site-directed mutagenesis of full-length constructs in pCDNA3.1
Myc-tagged vector was used to generate the C! T transversion in SEPT9_v4
commonly observed in the germline of patients with HNA. (B) Western blot
analysis of transient transfection in HeLa cell line of SEPT9_v4 wild-type
and the C262T point mutant under normoxic (N) and hypoxic (H) conditions,
re-probed for V5-tagged MEKK as transfection control and b-tubulin loading
control. (C) Results of real-time PCR control for Myc-tagged wild-type and
mutant constructs normalized to b-actin levels and expressed relative to
SEPT9_v4 wild-type levels under normoxia and hypoxia. The figure represents
the results of at least three independent experiments carried out in triplicate.
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and altered function. The result of these disease-associated
events is to deregulate the normal control of the SEPT9_v4
protein with its accumulation in cells. This protein can alter
other SEPT9 isoforms, for example, displacing SEPT9_v1
from filaments (21), and induce a number of cellular altera-
tions including perturbation of polarity, motility and microtu-
bule dynamics. SEPT9_v1 can also stabilize HIF1a (10), and
altered SEPT9_v4 levels can thus perturb HIF1a via
SEPT9_v1. It would appear that cells use many methods to
regulate septin gene expression.
MATERIALS AND METHODS
DNA manipulations and construct generation
The SEPT9_v4 and SEPT9_v4 50-UTRs were amplified from
cDNA of the ovarian carcinoma cell line PEO4, as it was pre-
viously shown to contain both transcripts (20). The 50-UTRs
were amplified using primers incorporating HindIII restriction
sites (v4HindIIIF-50-ACTAGAAGCTTGTCAGTATGGAGG
AGGCGGA-30, v4HindIIF-50-CTCTAAAGCTTGTTGGCC
CGGGGCCTTCA-30, v4/v4ComR-50-AGTAAAAGCTTCC
TCCGGTGGGCTGACTC-30) and inserted upstream of the
firefly luciferase reporter in the PGL-2 promoter (Promega)
vector generating the plasmids v4F/R and v4F/R. Similarly,
deletion constructs were produced by PCR amplifying and
subcloning fragments of exon 3 into PGL-2 promoter, gener-
ating ComF/R, v4UnF/R, v4F/R, 0–174, 0–278, 123–174,
123–278, 123–416, 243–278, 243–416 (ComHindIIF-50-AC
TGAAAGCTTCCTTGAAAAGAACTTTTGA-30, v4UnHind
IIR-50-CTCGAAAGCTTCTTGCAGGAACCAAGACA-30,
v4UnHindIIR-50-ACGATAAGCTTCTGGGCCACTGGAG-
TCACCAA-30, 174R-50-AGACTAAGCTTGTTGGCTTAGG
GAGTCCACA-30, 278R-50-AGACTAAGCTTCTGCTTGGA
CGAGATGTCAA30, 123F-50-AGACTAAGCTTGGCGTGA
AGAACTCAGAACC-30, 243F-50-AGACTAAGCTTGCACT
GAGCTGTCCATTGAC-30). Promoterless constructs were
generated by excision and sub-cloning into the HindIII site
in the MCS of the promoterless PGL-Basic vector (Promega)
upstream of the firefly luciferase reporter to generate
Bv4F/R, B-v4F/R and B-CF/R.
Full-length constructs were generated by overlapping PCR
utilizing products generated by amplification of 50-UTR
using forward primers v4HindIII/v4HindIIIF and reverse
primer in exon 3 (ABO16R-50 GCATCTGGATCTCCCCCTC
TTGG-30); with product amplified from SEPT9_v1 construct
utilizing forward primer in exon 3 (ABO15F-50- CGGCGCA
CTGAGCTGTCCAT-30) and reverse primer to the extreme 30
end of coding region incorporating an XhoI restriction site
(FLXhoIR-50-AGGGTGCCTCGAGCATCTCCGGGGCTT-30).
These products were combined and amplified with extreme 50
(v4HindIIIF/v4HindIIIF) and 30 primer (FLXhoI) and sub-
jected to further PCR and the resulting full-length product
digested and inserted into the HindII and XhoI restriction
sites in the MCS of pcDNA3.1-Myc/His B(þ) vector (Invitro-
gen). In all full-length constructs, the 30splice variant ‘a’ was
used (18). Point mutants, A7! T, A240! T; C262! T,
were introduced by site-directed mutagenesis using the Quik-
Change II SDM kit (Stratagene), using oligonucleotide
primers (A7TF-50-AGTTAAGCTTGTCAGTTTGGAGGAG
GCGGACC-30, A7TF-50-GGTCCGCCTCCTCCAAACTGAC
AAGCTTAACT-30, A240TF-50-GAGTGGCTGGGATTGGG
CGCAGGAGC-30, A240TR-50-GCTCCTGCGCCCAATCCC
AGCCACTC-30, C262TF-50-CCGAGCCGGTGTCCTGGCG
CACTGAGCTG-30, C262TR-50-CAGCTCAGTGCGCCA
GGACACCGGCTCGG-30) according to manufacturers’
instructions.
Bicistronic constructs PRF, PRMF and PhpRMF have been
described previously (48) and were a kind gift of Prof. Anne
Willis. Further constructs were generated by PCR amplifica-
tion of 50-UTRs and common region from PGL-2 constructs
utilizing forward primers containing SpeI restriction site
(v4SpeIF-50-ACTAGACTAGTGTCAGTATGGAGGAGGC-
GGA-30, v4SpeIF-50-CTCTAACTAGTGTTGGCCCGGGG
CCTTCA-30, ComSpeIF-50-ACTGAACTAGTCCTTGAAAA
GAACTTTTGA), reverse primer containing NcoI restriction
site (ComNcoIR-50- AGTAACCATGGCCTCCGGTGGGCT
GACTC-30) and inserted into those sites in the intercistronic
region of PRF or hairpin containing construct PhpRF to gen-
erate PRv4F, PRv4F and PRComF. Excision of the SV40
promoter from the PRF, PRMF, PRv4F and PRv4F was
achieved by sequential digestion with NheI and EcoRV,
blunt ending using the Klenow fragment of DNA PolI and
re-ligation. All PCRs were carried out with Proofreading Plati-
num Taq Hi-Fi (Invitrogen) according to manufacturers’
instructions, with annealing temperatures of 55–638C. All
plasmids were isolated using Plasmid Maxi/Midi/Mini-prep
kits (Qiagen) according to manufacturers’ instructions and
fully sequenced to confirm identity and orientation.
RNA analysis
RNA was extracted with RNA Stat-60 (Ambion) according to
manufacturers’ instructions, resuspended in DEPC-treated
sterile distilled water and subjected to RQ1 DNase digestion
(Promega) to remove any contaminating genomic and plasi-
mid DNA. RNA for northern blotting was further purified
using RNAeasy kit (Qiagen), eluted and added to MMF
loading buffer to final concentration: 50% formamide, 6% for-
maldehyde, 1 Blue juice (Invitrogen), denatured for 5 min at
658C and separated in 1.2% denaturing agarose gel containing
20 mM MOPS, 5 mM NaOAc, 1 mM EDTA, 6.3% formal-
dehyde and 1 mg/ml ethidium bromide. Transfer of RNA to
Hybond N nylon membrane was carried out by vacuum trans-
fer, membranes washed in 2 SSC (0.3 M NaCl, 0.03 M
C6H5Na3O7.2H20), dried and cross-linked by exposure to
UV. Northern probes were labelled using ready-to-go DNA
labelling beads (Amersham), according to manufacturers’
instructions, to which a32PdCTP (25 mCi) was added. Mem-
branes were hybridized with radio-labelled probe overnight
in hybridization buffer (0.332 M NaH2PO4.2H2O, 0.158 M
Na2HPO4 anhydrous) at 658C and washed with decreasing
concentration of SSC containing 0.1% SDS as required and
autoradiography carried out at 2808C.
For quantitative PCR, 1 mg of DNase-treated RNA was
reverse transcribed using the M-MLV RT kit (Invitrogen)
and random primers to produce cDNA according to manufac-
turers’ instructions. Quantitative RT–PCR was carried out
under standard conditions using DyNAmo SYBR Green
qPCR kit (Finnzymes). Denaturation was carried out for
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10 min at 948C, followed by 35 cycles of 948C for 10 s, 558C
for 10 s and 728C for 10 min and a final extension of 5 min at
948C. Myc-tagged transgene transcript levels were determined
utilizing forward primer in exon 12 (s9ex12F-50-
GTGGAGGAGAAGGAGCCAGA-30) and reverse primer to
vector-encoded Myc-tag (MycR-50-CAGATCCTCTTCTGAG
ATGAG-30). b-Actin was quantified as loading control
(BA7-50-CCCAGATCATGTTTGAGACCTTC-30, BA8-50-
GCCAGAGGCGTACAGGGATA-30 primers). Standard
curves were generated from 10-fold serial dilutions of
plasmid containing appropriate sequence and copy number
calculated by the comparative Ct method and expressed as a
percentage of the appropriate control/parental message and
normalized to b-actin level.
RNA models were produced using the mFOLD (49,50)
RNA structure prediction programme available online
(http://www.bioinfo.rpi.edu/applications/mfold/old/rna/).
Cell culture
Cos-7 cells were cultured in Dulbecco’s Modified Eagle’s
Medium supplemented with 10% foetal calf serum, 2 mM
L-glutamine, 50 units/ml penicillin, 50 mg/ml streptomycin
and 1 mM sodium pyruvate; HeLa cells were cultured in
RPMI 1640 (Life technologies) with L-glutamine, sup-
plemented with 10% FCS, 2.8 mM L-glutamine, 100 units/ml
penicillin and 100 mg/ml streptomycin in a humidified incuba-
tor containing 5% CO2. Cells were grown to 60–80% con-
fluency and transfected with 2 mg/well plasmid DNA in
six-well plates for western blotting and RNA extractions for
RT–PCR, 500 ng per well in 24 well-plates for luciferase
assays or 10 mg per 90 mM dish for RNA extraction for north-
ern blotting. Transfections were carried out using genejuice
(Novagen) according to manufacturers’ instructions and har-
vested 48 h post-transfection. For hypoxia experiments, cells
were transferred to a hypoxic chamber (1% O2, 5% CO2)
24 h post-transfection and harvested following 24 h hypoxia.
For etoposide (Sigma) treatments, cells were switched to
media containing the drug 24 h post-transfection and incu-
bated for a further 24 h before harvest. For monocistronic luci-
ferase reporter experiments, the phRL-TK (Promega) plasmid
was co-transfected at a ratio of 1:4 with firefly luciferase
construct to normalize for transfection efficiency, whereas
full-length constructs were co-transfected with V5-tagged
MEKK expression construct.
Protein analysis and reporter gene assays
Proteins were subjected to SDS–PAGE using the Laemelli
method. Following separation, proteins were transferred to
PVDF and blocked for 1 h in 5% milk containing 10 mM tris
incubated overnight at 48C with appropriate primary antibody.
Membranes were washed three times with TBS-T (10 mM tris
pH 8.0, 0.15 M NaCl, 0.1% triton X-100) following primary
and HRP-conjugated secondary (DAKO) incubations and
bands revealed by chemiluminescence (Pierce SuperSignal)
as described previously (51). Myc-tag (Clone 9E-10) and
b-actin monoclonal antibodies were purchased from Sigma
and V5-tag monoclonal from Invitrogen.
Cells transfected with reporter constructs were lysed in
Passive Lysis Buffer (Promega) and luciferase expression
was determined using the firefly LAR(20 mM tricine,
2.67 mM MgSO4.7H2O, 0.1 mM EDTA, 33.3 mM DTT,
530 mM ATP, 270 mM acetyl coenzyme A (lithium salt),
0.5 mM luciferrin, 0.25 mM (MgCO3)4Mg(OH)2.5H2O) and
Renilla coelenterazine (Nanoprobes) substrate (0.02 mg/ml).
Briefly, 20 ml of each lysate was duplicate-plated and firefly
(10s) and Renilla (2s) luciferase activity was assayed in an
EG&G Berthold microplate luminometer LB96V after
addition of 50 ml of substrate to each well.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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